The Adiana System is designed to provide a minimally-invasive, non-incisional alternative to traditional, surgical means of female sterilisation.
The Adiana procedure utilises hysteroscopy, generally requires only local anaesthesia, and can be performed in the outpatient setting. Patients are normally able to return to work or resume their everyday activities within a day. The Adiana Pivotal Trial (“A 12-Month Prospective Evaluation of Transcervical Sterilisation Using implantable Matrices’’ Vancaillie, Anderson and Johns) was published in the December edition of Obstetrics and Gynecology, the Journal of the American College of Obstetrics and Gynecology. This prospective multicentre study enrolled 770 women to evaluate Adiana’s performance with 1-year follow-up and was the basis for clinical submissions for both the CE Marking and the Food and Drug Administration (FDA) in the United States. The procedure showed a strong safety profile, with very high device placement success, patient tolerance, comfort, and satisfaction. Adiana was also found to be an easy and quick procedure that is well-suited as an outpatient procedure with comparable efficacy to other sterilisation methods. For further information please contact Hologic or visit www.Adiana.co.uk